BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh
BBCi CATEGORIES   TV   RADIO   COMMUNICATE   WHERE I LIVE   INDEX    SEARCH 

BBC NEWS
 You are in:  Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 


Commonwealth Games 2002

BBC Sport

BBC Weather

SERVICES 
Monday, 13 May, 2002, 23:20 GMT 00:20 UK
Optimism over MS cannabis
Tablets
It is hoped that cannabis will relieve MS pain
A British scientist is still hopeful that cannabis extracts will relieve the symptoms of multiple sclerosis (MS) patients - despite disappointing research results.

Testimonies from many MS patients suggest that the drug is helpful in relieving symptoms such as spasticity - a painful rigidity of muscles experienced by many.

However, a small Dutch study of only 16 MS patients given cannabis extract in capsule form found no apparent benefits.


I have many patients on my trials coming back saying cannabis has improved their quality of life

Dr William Nottcutt, James Paget Hospital
Despite this, Dr William Nottcutt, a consultant in pain management from the James Paget Hospital in Norfolk, said other research projects now coming to fruition were likely to produce more positive results.

He said: "This is one study among dozens being conducted into MS.

"I have many patients on my trials coming back saying cannabis has improved their quality of life."

The Dutch study, published in the journal Neurology, involved patients with severe spasticity.

They were given either a synthetic version of a cannabis chemical, or extracts of the plant itself.

Some were given a placebo - a capsule containing no active ingredient.

However, after four weeks of treatment, there was no discernable difference in the level of spasticity.

Fared worse

And when the patients were asked to rate their own progress, those on the active drug treatment actually believed they were worse off.

Dr Joep Killestein, who led the study, said the tiny number of patients involved meant that no firm conclusions could be drawn.

He also offered some explanations as to the lack of effect.

He said: "One could be the way that the drug was given in a capsule."

He also said the relatively low doses might also be to blame.

Dr Nottcutt told BBC News Online: "We have been giving patients the drug through a nasal spray so we can get them up to the right dosage very quickly.

"We tend to work on the most difficult patients - and with these, it isn't always certain that the drugs will work."

See also:

21 Mar 00 | Medical notes
Cannabis: The debate
05 Jul 01 | Health
Cannabis 'not medical panacea'
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories